dc.contributor
Institut Català de la Salut
dc.contributor
[Dominguez-Mozo MI] Grupo de Investigacion de Factores ambientales en enfermedades degenerativas, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Red de Enfermedades Inflamatorias (REI), Red Española de Esclerosis Múltiple, Madrid, Spain. [López-Mecández D] Department of Clinical Analysis, Hospital Clínico San Carlos, Instituto de Medicina del Laboratorio (IML), Madrid, Spain. [Villar LM, Villarrubia N] Servicio de Inmunología, Hospital Universitario Ramon y Cajal, Red de Enfermedades Inflamatorias (REI), Red Española de Esclerosis Múltiple, Madrid, Spain. [Costa-Frossard L] Servicio de Neurología, Hospital Universitario Ramon y Cajal, Red de Enfermedades Inflamatorias (REI), Red Española de Esclerosis Múltiple, Madrid, Spain. [Aladro Y] Servicio de Neurología, Hospital Universitario de Getafe, Spain. [Montalbán X, Comabella M] Servei de Neurologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
López-Mecández, Daniel
dc.contributor.author
VILLARRUBIA, NOELIA
dc.contributor.author
Dominguez-Mozo, Maria Inmaculada
dc.contributor.author
Villar, Luisa M
dc.contributor.author
Costa-Frossard França, Lucienne
dc.contributor.author
Aladro, Yolanda
dc.contributor.author
Comabella Lopez, Manuel
dc.contributor.author
Montalban, Xavier
dc.date.issued
2025-04-02T12:07:50Z
dc.date.issued
2025-04-02T12:07:50Z
dc.identifier
Dominguez-Mozo MI, López-Mecández D, Villar LM, Costa-Frossard L, Villarrubia N, Aladro Y, et al. Short-chain fatty acids in multiple sclerosis: Associated with disability, number of T2 lesions, and inflammatory profile. Ann Clin Transl Neurol. 2025 Mar;12(3):478–90.
dc.identifier
http://hdl.handle.net/11351/12880
dc.identifier
10.1002/acn3.52259
dc.identifier
001436692400001
dc.description.abstract
Short-chain fatty acids; Multiple sclerosis; Disability
dc.description.abstract
Ácidos grasos de cadena corta; Esclerosis múltiple; Discapacidad
dc.description.abstract
Àcids grassos de cadena curta; Esclerosi múltiple; Discapacitat
dc.description.abstract
Objective
An alteration in the composition of the intestinal microbiota has been observed in patients with multiple sclerosis (pwMS) with respect to healthy controls (HC). Microorganism-derived metabolites such as short-chain fatty acids (SCFA) have been suggested to play a role in the disease. Thus, to analyze the association of SCFA with clinical and radiological parameters of the disease and with those related to the inflammatory response of the immune system.
Methods
Multicentric observational retrospective cross-sectional study. In addition 161 pwMS and 130 HC were included. The following plasma SCFA were analyzed using liquid chromatography coupled to mass spectrometry: acetate (AA), propionate (PA) and butyrate (BA). Blood cell subpopulations and cytokine expression were analyzed by flow cytometry.
Results
Plasma PA and PA/AA ratio was lower in pwMS than in HC (P = 0.0001, and P = 0.00005, respectively). PA/AA and BA/AA ratios were lower in pwMS with higher disability (P = 0.001, and P = 0.001, respectively). T2 lesion load inversely correlated with PA/AA (r = −0.353; P = 0.002) and BA/AA (r = −0.322; P = 0.005) ratios. Plasma PA/AA and/or BA/AA ratios negatively correlated with the following pro-inflammatory cytokines producing cells: GM-CSF+CD4+T, GM-CSF+CD8+T, TNF-alpha+CD4+T, TNF-alpha+CD8+T, IFN-gamma+CD4+T, IFN-gamma+CD8+T, and TNF-alpha+B cells.
Interpretation
In MS, plasma PA/AA and BA/AA ratios are unbalanced, promoting an environment that could be boosting the mechanisms underlying the pathogenesis of the disease. Since we have found statistical significant associations with the EDSS and the number of T2 lesions, but not with the number of relapses or gadolinium enhancing lesions, PA/AA and BA/AA ratios could be more associated with those mechanisms of the disease related to the neurodegenerative processes than those related with the activity of the disease.
dc.description.abstract
This work was financially supported by Ministerio de Ciencia e Innovación (Proyectos de generación de conocimiento)-Fondo Europeo de Desarrollo Regional (Feder) (PID2021-126041OB-I00) and “Fundación LAIR”.
dc.format
application/pdf
dc.relation
Annals of Clinical and Translational Neurology;12(3)
dc.relation
https://doi.org/10.1002/acn3.52259
dc.relation
info:eu-repo/grantAgreement/ES/PEICTI2021-2023/PID2021-126041OB-I00
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Esclerosi múltiple
dc.subject
CHEMICALS AND DRUGS::Lipids::Fatty Acids::Fatty Acids, Volatile
dc.subject
DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis
dc.subject
DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Inflammation
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::lípidos::ácidos grasos::ácidos grasos volátiles
dc.subject
ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple
dc.subject
ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::inflamación
dc.title
Short-chain fatty acids in multiple sclerosis: Associated with disability, number of T2 lesions, and inflammatory profile
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion